Skip to main content
Unchecking box will stop auto data updates
Delayed Price USD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 2.4000
Day High 2.8000
Open:2.6000
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

More stories below advertisement

FEATURE-EMPTY
Description
Marina Biotech, Inc., formerly known as MDRNA, Inc., is a biotechnology company, focused on the development and commercialization of therapeutic products based on RNA interference (RNAi). The Company's pipeline currently includes a clinical program in Familial Adenomatous Polyposis (a precancerous syndrome) and two preclinical programs in hepatocellular carcinoma and bladder cancer. Marina's goal is to improve human health through the development of RNAi-based compounds and drug delivery technologies that together provide superior therapeutic options for patients. Marina Biotech, Inc. is headquartered in Bothell, Washington.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Stock Reports +

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

Non Selective COX Inhibitor - Pipeline Insight, 2019 Featuring Marina Biotech, Pfizer, and LTT Bio-Pharma - ResearchAndMarkets.com
BusinessWire - Fri Feb 22, 7:11AM CST
BusinessWire - CMTX
Fri Feb 22, 7:11AM CST
The "Non Selective COX Inhibitor - Pipeline Insight, 2019" drug pipelines has been added to ResearchAndMarkets.com's offering.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 2.0000 +35.00% increase
on 08/11/17
Period Open:3.8000
Price movement based on the high, low and last over the given period.
5.0000 -46.00% decrease
on 08/04/17
-1.1000 (-28.95%) decrease
since 07/28/17
3-Month 2.0000 +35.00% increase
on 08/11/17
Period Open:3.1350
Price movement based on the high, low and last over the given period.
5.0000 -46.00% decrease
on 08/04/17
-0.4350 (-13.88%) decrease
since 05/26/17
52-Week 0.7550 +257.62% increase
on 11/23/16
Period Open:1.4500
Price movement based on the high, low and last over the given period.
5.0000 -46.00% decrease
on 08/04/17
+1.2500 (+86.21%) increase
since 08/26/16

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2019.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).